Blue Cross® Blue Shield® of Michigan, Blue Care Network and AIM Specialty Health® (AIM) recognize the key role medical oncology practices play in the delivery of high-value, high-quality cancer care. We also recognize the challenges you face both in keeping current with treatment advances and ensuring affordable care for your patients. Together, we are implementing a program to promote evidence-based, high-value care for members undergoing medical oncology treatments. This site was developed to support your oncology practice as you participate in the program.
Benefits to your practice and patients
- Synchronization with plan medical policy. All prescribed regimens are reviewed in real time for benefit coverage under plan medical policy.
- Actionable information. When your practice prescribes a cancer treatment regimen for a patient and submits it to AIM for review, the prescribed regimen is compared against a comprehensive library of current, evidence-based AIM Cancer Treatment Pathways. If the planned regimen is not aligned with an AIM Pathway, information on evidence-based alternative regimens may be presented for your review.
- Enhanced reimbursement. By choosing AIM Cancer Treatment Pathways regimens when clinically appropriate, your practice may be eligible for enhanced reimbursement**.
** BCBS in-network providers in Alabama, Arkansas, California, Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Michigan, Missouri, Nevada, New Hampshire, New York, North Carolina, Ohio, Virginia or Wisconsin may be eligible to receive enhanced reimbursement.
Review the FAQ found on the Resources page for more details.